Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

PCR Markets: Global Analysis and Opportunity Evaluation 2017 - 2020

Be the first to review this product

Laboratory Markets Limited has completed a comprehensive market study of the global use of PCR covering established, recently developed and more specialised PCR methods and applications used in both...
You can choose to pay by purchase order during checkout

Availability: In stock

$5,800.00

* Required Fields

You can choose to pay by purchase order during checkout
Laboratory Markets Ltd

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description

Details

Laboratory Markets Limited has completed a comprehensive market study of the global use of PCR covering established, recently developed and more specialised PCR methods and applications used in both clinical and research laboratory settings. PCR 2016 profiles the use of these methods across more than 23,000 clinical and research organisations, encompassing 12 global regions and 158 countries. Details of these end-user organisations by name are provided as part of this report. 

These new findings are the result of a detailed three-year market study by Laboratory Markets Limited, covering the period up until May 2016. These leading market data are combined and analysed alongside findings on PCR growth and end-user costs from four other independent market studies, carried out by Laboratory Markets Limited. These four studies involved the participation of more than 1,700 PCR end-users. 

Data presented in PCR 2016 are from more than 75,000 PCR clinical and research studies carried out by experienced PCR end-users. These end-users are major decision-makers in the selection and purchase of PCR-related products and these 'real world' market data give in-depth information on the current and future use of PCR, in addition to % growth, costs, trends and opportunities. 

End-user organisations by name are identified in all key sectors and segments of this market study. Findings are provided as a PDF report, together with the full PCR 2016 market database created and compiled during this extensive market study. The data provided enables PCR suppliers to easily and rapidly identify, analyse and profile areas of the PCR market that offer the greatest business opportunities to their own companies. 

The extensive market database provided with the report augments the detailed market findings presented in the PDF report, allowing rapid and easy in-depth analysis across all PCR markets. This database can be shared across all departments and subsidiaries of purchasing organisations. 

These new study findings provide a considerable wealth of market information to suppliers in the PCR, molecular biology and molecular diagnostics fields. They assist suppliers to identify new PCR market opportunities and give powerful strategic insights into new developments and applications. 

Key Features 1. Enables suppliers to profile key areas of PCR markets relating to their own PCR products and services and provides qualified prospects by end-user organisation name 2. Analyses and ranks PCR practices by country, organisation type, methods, applications, disease and research areas, viruses, bacteria and others, helping suppliers to identify 'high opportunity' sectors relevant to their current PCR products and future plans in these fields, supporting targeted marketing and reducing costs and risks 3. Provides key information in growing and developing areas of the PCR market, helping suppliers focus resources on PCR growth areas, supporting new sales opportunities in important market sectors 4. Helps suppliers to evolve and extend their own strategic visions, future plans and operational activities in the PCR field 5. Enables suppliers to identify, analyse and rank end-user practices and needs and build new customer relationships in leading PCR market sectors

   
This study provides detailed market data on the use of PCR across all global regions, covering 158 countries. Leading countries in terms of PCR use are also identified, together with top users by country state or county, city and organisation name. 
PCR 2016 identified more than 23,000 PCR end-user laboratories, each of which are profiled across key market areas allowing the analysis of all key sectors, developments and opportunities in this field.
Organistion types using PCR are profiled as part of this study including hospitals, research institutes, universities and companies. The departments in which these organisations use these methods are also identified. 
More than 105 individual PCR methods are profiled, from those most commonly used such as qPCR and RT-PCR, through to newer or more specialised methodologies such as digital PCR, FRET PCR and COLD-PCR. 
The PDF report provides an in-depth analysis of key findings across all major sectors, and identifies key sector developments and opportunities, growth and end-user costs in this diverse and growing field. 
Key PCR market areas have been profiled including global regions, countries, country states/counties, cities, end-user organisations, methods, applications, other moleculer methods, diseases, viruses and bacteria and other areas. 
These findings assist suppliers in the PCR fields to keep pace with end-users' laboratory activities and needs. They also offer a highly cost-effective sourcs of marketing and sales related information and give new insights into today's evolving clinical and research PCR fields. 
   
   
The PCR 2016 database contains more than 75,000 individual records of PCR end-user organisations, covering more than 70,000 PCR studies reported betweeen January 2013 and May 2016. It gives easy access to datasets and provides valuable PCR market insights. 
This datebase is provided as an easy-to-use Excel file which can be rapidly analysed using Pivot Tables. This allows tables and graphs of all PCR market sectors or segments to be easily generated in minutes.
Pivot table analysis allows the analysis of PCR market data across all segments, allowing established PCR methods and applications to be analysed, as well as newer devlopments and market opportunities. 
Data contained in the PCR 2016 database allows side-by-side comparisons of current and developing PCR practices and applications across key sectors of this market. 
The database can be shared across all subsiquaries of purchasing organisations. This allows data analysis from multiple perspectives, from marketing and sales through to R&D and new product innovation. 
This database enables easy analysis of PCR practices from the methods and applications PCR end-users are running, to more powerful analyses of relationships in the market, offering market predictions and trend analysis. 
The market data presented in PCR 2016 provides a valuable source of qualified sales prospects, based on the current and developing use of PCR across multiple organisations and sectors. 


PCR 2016 Market Study

1. PCR Laboratories 

This market study covers more than 23,000 PCR end-user laboratories globally, which are identified by organisation name and department, country and in most cases, by city. The top PCR end-users (based on the numbers of reported PCR studies) can be identified, as well as the 'top growers' based on the numbers of PCR studies. These data enable suppliers to identify sales prospects and opportunities based on current use and market developments and trends. Findings on individual PCR laboratories can be segmented across all areas of the study.

2. PCR Methods 

Since the development of PCR methodologies in the 1980s, these methods have evolved and advanced in many ways. These advances continue as innovators seek to enhance capabilities in specific application areas. While methods such as real-time quantitative PCR (qPCR) and Reverse Transcription PCR (RT-PCR) are commonly used, this study identifies more than 100 specific PCR methods (and the laboratories where they are being used) including rapidly advancing new methods such as digital PCR. 

Findings on individual PCR methods can be segmented across all areas of the study versus other PCR methods, PCR applications, clinical and research use, diseases, virus and bacteria types, nucleic acid types, the use of other molecular methods, global regions, countries, states or counties, cities, organisation names, organisation types (companies, hospitals, research institutes, universities, veterinary organisations etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study. 

The PCR methods identified and profiled in this study include (in alphabetical order) ACB-PCR, Allele-specific PCR, Amplification by PCR, AP-PCR, ARMS-PCR, Assembly PCR, Asymmetric PCR, Breakpoint PCR, Chip PCR, ChIP-PCR, Classical PCR, COLD-PCR, Colony PCR, dcRT-MLPA, Differential DNA Denaturation PCR, Digital PCR, DMAMA PCR, DOP-PCR, duplex RT-PCR, eHT-PCR, ERIC-PCR, FAP PCR, FLASH-PCR, Flow Through PCR, FRET PCR, Fusion PCR, Gap PCR, Helicase-Dep Amplification, HRM PCR, ICE-COLD-PCR, Immunocapture PCR, Inverse PCR, Isothermal PCR, LAMP, LA-PCR, Ligation-Mediated PCR, Linker-Adapted PCR, Long PCR, MAMA-PCR, MAP PCR, MDA-PCR-SBT, Methylation-Sensitive AP PCR, Methylation-Specific PCR, Microsphere-Based Array, MLPA, MS-MLPA, Mult displ Amplification, Multiplex PCR, Multiplex qPCR, Multiplex RT-PCR, Multiplex Taqman, Mut Sep PCR, NASBA, Nested PCR, One-step multiplex qRT-PCR, Overlap extension PCR, Overlap PCR, Panbacterial PCR, PCR array, PCR ELISA, PCR Fingerprinting, PCR Screening, PCR Sequencing, PCR SSP, PCR targeting, PCR testing, PCR-based screening, PCR-DGGE, PCR-fluorescence probe, PCR-free MPS library prep, PCR-LDR, PCR-RFLP, PCR-SBE, PCR-SSO, PCR-SSOP, PCR-SSP, PCR-targeted sequencing, PMA-qPCR, Polymerase Cycling Assembly, Polymorphism-PCR, qPCR, qRT-PCR, RACE-PCR, RAPD PCR, rep-PCR, RFLP-PCR, RFQ-PCR, RNA PCR, RNA-Seq, RNA-Specific PCR, RT-MLPA, RT-PCR, rzPCR, Single cell PCR, SOE PCR, Solid Phase PCR, Species specific PCR, specific-to-allele PCR-FISH, SSP-PCR, TAIL-PCR, Taqman PCR, Taqman qPCR, T-ARMS PCR, Touchdown PCR, Trap PCR, Trap PCR ELISA, TTGE PCR and Type-Specific PCR. 

3. PCR Applications

PCR methodologies are indispensable in molecular biology and are used in an increasingly diverse range of applications, from fundamental research to routine clinical diagnostics and sequencing. This study identified more than 155 PCR applications, which are presented in this report. While applications such as gene expression and mutation analysis are important established uses of PCR, findings in this study enable the relative importance of each of the applications to be analysed and profiled. 

Findings on individual PCR applications can be segmented across all areas of the study (versus other PCR methods, other PCR applications, clinical and research use, diseases, virus and bacteria types, nucleic acid types, the use of other molecular methods, global regions, countries, states or counties, cities, organisation names, organisation types (companies, hospitals, research institutes, medical and research centers, universities, veterinary organisations etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study. 

PCR applications identified in this study are (in alphabetical order) Allele frequencies, Allele size, Amplification, Antibiotic resistance, Antimicrobial susceptibility, Antiseptic resistance, Antiviral Resistance, Apoptosis, Bacteria identification, Bacterial concentrations, Bacterial DNA, Bacterial Load, Bacterial populations, Bacterial sensitivity, Bacterial Strains, Biomarkers, Blood screening, Cell cycle, Cell expression, Cell Lysis, Chromosome abnormalities, Chromosome analysis, Clinical Therapeutics, Clonal relationships, Cloning, Commensal bacteria, Community profiling, Cytogenetic, Cytokines, Degree of homology, Diagnosis, DNA analysis, DNA breakage, DNA copies, DNA damage, DNA degradation, DNA levels, DNA methylation, DNA ploidy, DNA profiling, DNA quantification, DNA sequencing, DNA-barcoding, Drug resistance gene, Environmental monitoring, Epidemiology, Fingerprinting, Food testing, Gene abundance, Gene alterations, Gene assay, Gene copies, Gene deletions, Gene detection, Gene down-regulation, Gene expression, Gene fusion, Gene Identification, Gene interactions, Gene Knockdown, Gene level, Gene Methylation, Gene mutations, Gene overexpression, Gene polymorphism, Gene regulation, Gene variants, Genetic disease, Genetic mapping, Genomic DNA, Genomics, Genotyping, Haplotypes, Host-pathogen interactions, Infections, Infectious bacteria, infectious disease, Karyotyping, Leukocyte telomere length, Metagenomics, Microarray, Microbial identification, Microbiota, MicroRNA, Microsatellite, Microsatellite typing, Mitochondrial DNA, Mobile elements, Molecular characterization, Molecular tests, Monoclonality, mRNA, Mutations, New viruses, Outbreak investigation, Patient monitoring, PCR tests, Phylogenetic analysis, Population dynamics, Prognosis, Quantitation of viruses, Rapid tests, Receptor expression, Recombinant DNA, Residual disease, Resistance, Resistance genes, RNA quantification, RNA sequence analysis, Screening, Senescence, Sequence-tagged sites, Serotyping, Signaling pathway, Single nucleotide polymorphism, Single nucleotide repeats, siRNAs, Site-directed mutagenesis, Species identification, STR typing, Strain detection, Strain typing, Telomerase, Tissue expression, Tissue typing, Transcript detection, Transcript levels, Transcript numbers, Transcript quantification, Transcriptional activities, Transcriptional regulators, Transcriptome, Transcripts, Translocations, Treatment decisions, Tumor-associated genes, Upregulations, Vaccination, Vector borne pathogens, Veterinary, Viral DNA, Viral load, Viral replication, Viral RNA copies, Viral Strains, Viral typing, Viral vector, Virulence factors, Virulence genes, Virulence traits, Virus concentrations, Virus detection, Virus genes, Virus subtypes, Viruses and Water safety

4. Other Molecular Methods

PCR is used alongside other molecular methods and these are also profiled as part of this study. More than 60 other molecular methods are profiled in this study from commonly used Western blot and microarray, through to gene-knockout and CRISPR. 

Findings on other molecular methods can be segmented across all areas of the study versus other PCR methods, other PCR applications, clinical and research use, diseases, virus and bacteria types, nucleic acid types, global regions, countries, states or counties, cities, organisation names, organisation types (companies, hospitals, research institutes, medical and research centers, universities, veterinary organisations etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study. 

Other molecular methods identified include (in alphabetical order) alanine scanning, ATAC-seq, ChIA-PET, ChIP-exo, ChIP-on-chip, ChIP-sequencing, Chromatin immunoprecipitation, Cloning, Comet assay, Comparative Genomic Hybridization Array, CRISPR, Cycling Probe, Diversity Array Technology, DNA cloning, DNA footprinting, DNA Methylation Array, DNA microarray, DNA Patterns, DNA sequencing, DNase-Seq, Electrophoresis, Electrophoretic mobility shift assay, Exome sequencing, Exon arrays, Far-western blotting, Fluorescence in-situ hybridization, Förster resonance energy transfer, Gene Array, Gene knockout, Immunoprecipitation, In Situ Hybridization, Ion Torrent, Karyotyping Massively Parallel Signature Sequencing, Microarray, Microsatellite enrichment, miRNA Array, Multilocus Sequence Typing, Mutagenesis, Next-Generation Sequencing, Northern blot, Nuclease protection assay, Oligonucleotide Array, Oligotyping, Photoaffinity labeling, Plasmidome, Pyrosequencing, Ribosomal Intergenic Spacer analysis, Ribosome profiling, Sanger sequencing, Shotgun Sequencing, Southern blot, Southwestern blot, STable-isotope probing, Strand Displacement Amplification, Strep-tag, Subcloning, Suspension array technology, Taqman Array, Tiling Array, Transcriptome Array, Viability assay, Western blot and Yeast two-hybrid,

5. Diseases

Findings from this study enable suppliers in the PCR, molecular biology and molecular diagnostics fields to identify and profile laboratories where PCR is used in specific disease areas. Findings on disease areas can be segmented across all areas of the study versus other PCR methods, other PCR applications, clinical and research use, other diseases, virus and bacteria types, nucleic acid types, global regions, countries, states or counties, cities, organisation names, organisation types (companies, hospitals, research institutes, medical and research centers, universities, veterinary organisations etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study. 

More than 1100 disease areas have been investigated and these include (in alphabetical order) AIDS, Alzheimer's Disease, Antibiotic Resistance, Asthma, Autoimmune Disease, Avian Influenza, Cancer–Bladder, Cancer–Breast, Cancer–Cervical, Cancer–Colon, Cancer–Endometrial, Cancer–Gastric, Cancer–Leukaemia, Cancer–Liver, Cancer–Lung, Cancer–lymphoma, Cancer–Oesophageal, Cancer–Ovarian, Cancer–Pancreatic, Cancer–Prostate, Cancer–Rectal, Cancer–Thyroid, Cancer–Ovarian, Cholera, COPD, Coronary Artery Disease, Cystic Fibrosis, Diabetes mellitus, Diabetes Type 1, Diabetes Type 2, Diarrhoea, Drug Resistance, Encephalitis, Endometriosis, Epilepsy, Gastroenteritis, Glioblastoma, Glioma, Heart Disease, Heart Failure, Hepatitis B, Hepatitis C, Hepatocellular Carcinoma, Hypertension, Hypoxia, Immunodeficiency, Infertility, Inflammatory Bowel Disease, Influenza A, Influenza B, Insulin Resistance, Kidney Disease, Leishmaniasis, Liver Cirrhosis, Liver Disease, Malaria, Melanoma, Meningitis, Metabolic Syndrome, Metastases, Multiple Myeloma, Myeloid Leukemia, Myocardial Infarction, Myopathy, nasopharyngeal carcinoma, Nephropathy, Neuroblastoma, Osteoarthritis, Osteoporosis, Osteosarcoma, Pancreatitis, Parkinson's Disease, Periodontal disease, Pneumonia, Polycystic Ovary Syndrome, Psoriasis, Pulmonary Fibrosis, Renal cell carcinoma, Renal Disease, Renal failure, Retinoblastoma, Retinopathy, Schizophrenia, Sclerosis, Skin lesion, Spinal cord injury, Squamous Cell Carcinoma, Stroke, Systemic Lupus, Thrombocytopenia, Toxoplasma, Toxoplasmosis, Trachoma, Traumatic brain injury, Tuberculosis, Urothelial carcinoma, Uveitis, Varicella, Vascular Disease, Visceral leishmaniasis and Vomiting,

6. Clinical and Research Use 

All PCR studies cited in this report were reviewed to establish the clinical (e.g. involving patients or volunteers) or research use of this technique. Findings on the clinical or research use of PCR can be segmented across all areas of the study versus other PCR methods, other PCR applications, clinical and research use, other diseases, virus and bacteria types, nucleic acid types, global regions, countries, states or counties, cities, organisation names, organisation types (companies, hospitals, research institutes, medical and research centers, universities, veterinary organisations etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study. 

7. Nucleic Acid Types

Findings from this study enable suppliers in the PCR field to identify and profile laboratories where PCR is used relating to specific nucleic acid types. Findings on nucleic acid types can be segmented across all areas of the study versus other PCR methods, other PCR applications, clinical and research use, other diseases, virus and bacteria types, other nucleic acid types, global regions, countries, states or counties, cities, organisation names, organisation types (hospitals, companies, research institutes, medical and research centers, universities, veterinary organisations etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study. 

Around 75 nucleic acids types have been investigated and these include (in alphabetical order) 12S rRNA, 16s ribosomal RNA, 16S rRNA, 16S-23S rRNA, 16SrDNA, 18S rDNA, 23S rRNA, 3CDR3 DNA, Archaeal DNA, Archived DNA, Bacterial DNA, B-cell DNA, Bisulfite-converted DNA, Blood DNA, ccfDNA, cDNA, Cell-free DNA, cfDNA, Chromosomal DNA, Circular DNA, Circulating DNA, Circulating nucleic acids, Circulating RNA, Circulating tumor DNA, ctDNA, DNA, DNA extraction, DNA extracts, DNA hypermethylation, DNA isolation, DNA markers, DNA methylation, Fetal DNA, Fish DNA, Fungal DNA, Genomic DNA, HIV-1 DNA, HPV DNA, HPV-16 DNA, HSV DNA, kDNA, Kinetoplast DNA, Leukocyte DNA, MicroRNA, miRNA, Mitochondrial DNA, mRNA, mtDNA, Noncoding RNA, Nuclear DNA, Parasite DNA, Pathogen DNA, piRNA, Plasmid DNA, Polymorphic DNA, Proviral DNA, Ribosomal RNA, RNA, RNA analysis, RNA extraction, rRNA, Single stranded DNA, siRNA, Small interfering RNA, Small nuclear RNA, snRNA, ssDNA, T-DNA, Total RNA, Transfer RNA, tRNA, Viral DNA, Viral RNA and Virus-specific DNA, 

8. Viruses 

Findings from this study enable suppliers in the PCR field to identify and profile laboratories where PCR is used relating to specific virus types. Findings on virus types can be segmented across all areas of the study versus other PCR methods, other PCR applications, clinical and research use, other diseases, other viruses, bacteria types, other nucleic acid types, global regions, countries, states or counties, cities, organisation names, organisation types (hospitals, companies, research institutes, medical and research centers, universities, veterinary organisations etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study. 

Around 390 virus types have been investigated and these include (in alphabetical order) African swine fever virus, Avian leukosis virus, Beak and feather disease virus, Betacoronavirus, Bluetongue virus, Bombyx mori nucleopolyhedrovirus, Bovine leukemia virus, Bovine viral diarrhea virus, Canine distemper virus,Cauliflower mosaic virus, Chicken anemia virus, Chikungunya virus, Citrus tristeza virus, Classical swine fever virus, Coronavirus, Cucumber mosaic virus, Cyprinid herpesvirus, Cytomegalovirus, Dengue virus, Duck circovirus, Enterovirus, Epstein-Barr virus, Equid herpesvirus, Feline calicivirus, Feline immunodeficiency virus, Feline leukemia virus, Foot-and-mouth disease virus, Frog virus, Gammapapillomavirus, Hepatitis, Herpes simplex, HIV, Hop stunt viroid, Human coronavirus, Human herpesvirus, Human metapneumovirus, Human papillomavirus, Human polyomavirus, Human respiratory syncytial virus, human T-lymphotropic virus, Infectious bursal disease virus, Infectious hematopoietic necrosis virus, Infectious pancreatic necrosis virus, Influenza,
Japanese encephalitis virus, JC polyomavirus, Lymphocystis disease virus, Mamastrovirus, Measles virus, Mouse mammary tumor virus, Mumps virus, Murine leukemia virus, Newcastle disease virus, Nipah virus, Norwalk virus, Orf virus, Ostreid herpesvirus, Ovine herpesvirus, Parainfluenza virus, Parapoxvirus, Parechovirus, Parvovirus, Pegivirus, Pepper mild mottle virus, Polyomavirus, Porcine circovirus, Porcine epidemic diarrhea virus, Porcine reproductive and respiratory syndrome virus, Potato virus, Puumala virus, Rabies virus, Respiratory syncytial virus, Reticuloendotheliosis virus, Rice stripe virus, Rift Valley fever virus, Rotavirus, Rubella virus, Sacbrood virus, Salivirus, Sendai virus, Seoul virus, Simian foamy virus, Simian immunodeficiency virus, Simian virus, Sindbis virus, Suid herpesvirus, Tembusu virus, Tick-borne encephalitis virus, Tobacco mosaic virus, Tobacco rattle virus, Tomato torrado virus, Tomato yellow leaf curl virus, Torque teno virus, Triatoma virus, Vaccinia virus, Varicella Zoster, Viral hemorrhagic septicemia virus, West Nile virus, White spot syndrome virus, Yellow fever virus and Zika virus.

9. Bacteria

Findings from this study enable suppliers in the PCR field to identify and profile laboratories where PCR is used relating to specific bacterial types. Findings on bacteria types can be segmented across all areas of the study versus other PCR methods, other PCR applications, clinical and research use, other diseases, viruses, other bacteria types, other nucleic acid types, global regions, countries, states or counties, cities, organisation names, organisation types (hospitals, companies, research institutes, medical and research centers, universities, veterinary organisations etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study. 

Around 710 bacteria types have been investigated and these include (in alphabetical order; Genus or Genus+Species) Acinetobacter baumannii, Actinobacteria, Aeromonas hydrophila, Aggregatibacter actino-mycetemcomitans, Agrobacterium, Agrobacterium tumefaciens, Anaplasma phagocytophilum, Bacillus subtilis, Bacillus thuringiensis, Bordetella pertussis, Borrelia, Borrelia burgdorferi, Brucella, Campylobacter, Campylobacter jejuni, Cardiobacterium hominis, Chlamydia, Chlamydia trachomatis, Clostridium, Clostridium difficile, Clostridium perfringens, Coxiella burnetii, Cyanobacteria, Ehrlichia canis, Enterobacter, Enterococcus, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Firmicutes, Flavobacterium, Francisella tularensis, Haemophilus influenzae, Helicobacter, Helicobacter pylori, Klebsiella pneumoniae, Lactobacillus, Lactobacillus plantarum, Lactococcus lactis, Legionella, Legionella pneumophila, Leptospira, Leptospira interrogans, Leuconostoc van, Listeria monocytogenes, Mycobacteria, Mycobacterium, Mycobacterium avium, Mycobacterium bovis, Mycobacterium leprae, Mycobacterium tuberculosis, Mycoplasma, Mycoplasma pneumoniae, Mycoplasmas, Neisseria gonorrhoeae, Neisseria meningitidis, Nontuberculous, Non-tuberculous mycobacteria, Paenibacillus, Pasteurella multocida, porphyromonas gingivalis, Prevotella, Proteus, Pseudomonas, Pseudomonas aeruginosa, Pseudomonas putida, Pseudomonas syringae, Rhizobia, Rickettsia, Rickettsiae, Salmonella, Salmonella enterica, Salmonella typhimurium, Sarcina, Shigella, Staphylococcus, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus, Streptococcus agalactiae, Streptococcus mutans, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus suis, Streptococcus thermophilus, Streptomyces, Treponema, Treponema denticola, Ureaplasma, Ureaplasma urealyticum, Vibrio, Vibrio alginolyticus, Vibrio anguillarum, Vibrio cholerae, Vibrio harveyi, Vibrio parahaemolyticus, Wolbachia, Xanthomonas, Yersinia and Yersinia enterocolitica. 

10. Global Regions 

Findings from this study enable suppliers in the PCR field to identify and profile laboratories where PCR is used relating to specific global regions. Findings on global regions can be segmented across all areas of the study (versus other PCR methods, other PCR applications, clinical and research use, other diseases, virus and bacteria types, other nucleic acid types, other global regions, countries, states or counties, cities, organisation names, organisation types (hospitals, companies, research institutes, medical and research centers, universities, veterinary organisations etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study. 

Thirteen global regions have been investigated, namely (in alphabetical order) Asia, Caribbean, Central Africa, Central America, Eastern Africa, Europe, Middle East, North America, Northern Africa, Oceania, South America, Southern Africa and Western Africa.

11. Countries 

Findings from this study enable suppliers in the PCR field to identify and profile laboratories where PCR is used relating to specific countries. Findings on specific countries can be segmented across all areas of the study versus other PCR methods, other PCR applications, clinical and research use, other diseases, virus and bacteria types, other nucleic acid types, global regions, other countries, states or counties, cities, organisation names, organisation types (hospitals, companies, research institutes, medical and research centers, universities, veterinary organisations etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study. 

Around 150 countries have been investigated and these include (in alphabetical order) Algeria, Argentina, Australia, Austria, Bahrain, Bangladesh, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Burkina Faso, Cambodia, Cameroon, Canada, Chile, China, Colombia, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Ecuador, Egypt, Estonia, Ethiopia, Finland, France, Georgia, Germany, Ghana, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jersey, Jordan, Kenya, Kuwait, Latvia, Lebanon, Lithuania, Luxembourg, Macedonia, Malaysia, Mexico, Morocco, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Palestine, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Republic of Korea, Romania, Russia, Saudi Arabia, Senegal, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sudan, Sweden, Switzerland, Syria, Taiwan, Tanzania, Thailand, Tunisia, Turkey, Uganda, UK, Ukraine, United Arab Emirates, Uruguay, USA, Venezuela, Vietnam and Zambia.

12. Organisation Types 

Findings from this study enable suppliers in the PCR field to identify and profile laboratories where PCR is used relating to specific organisation types. Findings on organisation types can be segmented across all areas of the study versus other PCR methods, other PCR applications, clinical and research use, other diseases, virus and bacteria types, other nucleic acid types, global regions, countries, states or counties, cities, organisation names, other organisation types (hospitals, companies, research institutes, medical and research centers, universities, veterinary organisations etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study. 

More than 40 organisation types have been investigated and these include (in alphabetical order) Academies, Agencies, Associations, Authorities, Boards, Bureaus, Centres, Clinics, Colleges, Commissions, Companies, Councils, Defence establishments, Directorates, Facilities, Foundations, Health Services, Hospitals, Institutes, Laboratories, Medical Centers, Medical Universities, Military establishments, Ministries, National Organisations, Naval organisations, Polytechnics, Projects, Schools, Services, Societies, Trusts, Universities and Veterinary.

13. Departments

Findings from this study enable suppliers in the PCR field to identify and profile laboratories where PCR is used relating to specific end-user departments. Findings on specific departments can be segmented across all areas of the study versus other PCR methods, other PCR applications, clinical and research use, other diseases, virus and bacteria types, other nucleic acid types, global regions, countries, states or counties, cities, organisation names, organisation types (hospitals, companies, research institutes, medical and research centers, universities, veterinary organisations etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study. 

Around 6800 end-user departments have been investigated and these include (in alphabetical order) Agriculture, Anatomy, Anaesthesiology, Animal Science, Biochemistry, Biochemistry and Molecular Biology, Biological Sciences, Biology, Biomedical Engineering, Biomedical Sciences, Biotechnology, Breast Surgery, Cardiology, Cardiothoracic Surgery, Cell Biology, Chemistry, Civil and Environmental Engineering, Clinical Biochemistry, Clinical Laboratory, Clinical Pathology, Clinical Sciences, Dermatology, Emergency, Endocrinology, Entomology, Epidemiology, Forensic Medicine, Gastroenterology, Gastroenterology and Hepatology, Gastrointestinal Surgery, General Surgery, Genetics, Geriatrics, Gynaecology, Gynaecology and Obstetrics, Hematology, Hepatobiliary Surgery, Histology and Embryology, Human Genetics, Immunology, Infectious Diseases, Internal Medicine, Laboratory Medicine, Life Sciences, Medical Biochemistry, Medical Biology, Medical Genetics, Medical Microbiology, Medical Oncology, Medicine, Microbiology, Microbiology and Immunology, Molecular Biology, Molecular Medicine, Nephrology, Neurology, Neuroscience, Neurosurgery, Obstetrics, Obstetrics and Gynaecology, Obstetrics and Gynaecology, Oncology, Ophthalmology, Oral and Maxillofacial Surgery, Orthodontics, Orthopaedic Surgery, Orthopaedics, Orthopaedic Surgery, Orthopaedics, Otolaryngology, Otolaryngology-Head and Neck Surgery, Otorhinolaryngology, Paediatrics, Parasitology, Pathobiology, Pathology, Pathology and Laboratory Medicine, Pathophysiology, Paediatric Surgery, Paediatrics, Periodontology, Pharmacology, Pharmacy, Physiology, Plant Pathology, Psychiatry, Radiation Oncology, Radiology, Respiratory Medicine,
Rheumatology, Stomatology, Surgery, Surgical Oncology, Thoracic Surgery, Urology, Veterinary Medicine, Virology and Zoology

14. States, Counties and Cities 

Findings from this study enable suppliers in the PCR field to identify and profile laboratories where PCR is used relating to specific states and cities. Findings on specific states/counties and cities can be segmented across all areas of the study versus other PCR methods, other PCR applications, clinical and research use, other diseases, virus and bacteria types, other nucleic acid types, global regions, countries, states or counties, cities, organisation names, organisation types (hospitals, companies, research institutes, medical and research centers, universities, veterinary organisations etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study. 

Around 790 states/counties and 3500 cities have been investigated. All leading states/counties and cities are included, each of which can be ranked according to the number of PCR studies reported. 

All 75,000+ studies using PCR are fully referenced, allowing PCR end-users to be identified by name alongside further details of their work. 

15. PCR Growth & Costs 

Findings from PCR 2016 are analysed alongside data on market % growth and end-user costs obtained during four other independent PCR studies by Laboratory Markets Limited, provided by more than 1,700 experienced PCR end-users.


Additional Information

Additional Information

Publisher name Laboratory Markets Ltd
Format PDF + Excel
Page count 118
Publication date 3 Oct 2016
Table of contents

Report Sample

Report Contents
(With Figures and Tables)

Chapter 1. PCR 2016
1.1 Conduct of study
1.2 Data Analysis
1.3 Study Data

Chapter 2. Global PCR
2.1 Global Regions
Figure 2.1. The global use of PCR (all regions and PCR methods 2013 to 2016)
Table 2.1. The global use of PCR (all regions and PCR methods 2013 to 2016)
Figure 2.2. The use of PCR in North America (all PCR methods 2013 to 2016)
Table 2.2. The use of PCR in North America (all PCR methods 2013 to 2016)
Figure 2.3. The use of PCR in Europe (all PCR methods 2013 to 2016)
Table 2.3. The use of PCR in Europe (all PCR methods 2013 to 2016)
Figure 2.4. The use of PCR in Asia (all PCR methods 2013 to 2016)
Table 2.4. The use of PCR in Asia (all PCR methods 2013 to 2016)
Figure 2.5. The use of PCR in South America (all PCR methods 2013 to 2016)
Table 2.5. The use of PCR in South America (all PCR methods 2013 to 2016)
Figure 2.6. The use of PCR in Middle East (all PCR methods 2013 to 2016)
Table 2.6. The use of PCR in Middle East (all PCR methods 2013 to 2016)
Figure 2.7. The use of PCR in Oceania (all PCR methods 2013 to 2016)
Table 2.7. The use of PCR in Oceania (all PCR methods 2013 to 2016)
Figure 2.8. The use of PCR in Central America (all PCR methods 2013 to 2016)
Table 2.8. The use of PCR in Central America (all PCR methods 2013 to 2016)
Figure 2.9. The use of PCR in North Africa (all PCR methods 2013 to 2016)
Table 2.9. The use of PCR in North Africa (all PCR methods 2013 to 2016)
2.2 Organisation Types
Figure 2.10. Top-10 PCR organisation types (all regions and PCR methods 2013 to 2016)
Table 2.10. Top-10 PCR organisation types (all regions and PCR methods 2013 to 2016)
2.3 PCR Methods
Figure 2.11. Top-10 PCR methods (all regions and PCR methods 2013 to 2016)
Table 2.11. Top-10 PCR methods (all regions and PCR methods 2013 to 2016)
2.4 PCR Applications
Figure 2.12. Top-10 PCR applications (all regions and PCR applications 2013 to 2016)
Table 2.12. Top-10 PCR applications (all regions and PCR applications 2013 to 2016)
2.5 PCR Clinical & Research
Figure 2.13. Clinical /research use pf PCR (all regions and PCR applications 2013 to 2016)
Table 2.13. Clinical/Research use of PCR (all regions and PCR applications 2013 to 2016)
2.6 Diseases
Figure 2.14. PCR disease areas (all regions and PCR applications 2013 to 2016)
Table 2.14. PCR disease areas (all regions and PCR applications 2013 to 2016)
2.7 Viruses by PCR
Figure 2.15. PCR virus areas (all regions and PCR applications 2013 to 2016)
Table 2.15. PCR virus areas (all regions and PCR applications 2013 to 2016)
2.8 Bacteria by PCR
Figure 2.16. PCR bacteria areas (all regions and PCR applications 2013 to 2016)
Table 2.16. PCR bacteria areas (all regions and PCR applications 2013 to 2016)
2.9 Nucleic Acids
Figure 2.17. PCR nucleic acid types (all regions and PCR applications 2013 to 2016)
Table 2.17. PCR nucleic acid types (all regions and PCR applications 2013 to 2016)
2.10 Departments
Figure 2.18. PCR departments (all regions and PCR applications 2013 to 2016)
Table 2.18. PCR departments (all regions and PCR applications 2013 to 2016)
2.11 Nucleic Acids
Figure 2.19. PCR departments (all regions and PCR applications 2013 to 2016)
Table 2.19. PCR departments (all regions and PCR applications 2013 to 2016)
2.12 Other Molecular Techniques
Figure 2.20. Other techniques (all regions and PCR applications 2013 to 2016)
Table 2.20. Other techniques (all regions and PCR applications 2013 to 2016)
2.12 Conclusions

Chapter 3. PCR by Country
3.1 Countries
Figure 3.1. PCR use by country (Top-10 countries and PCR methods 2013 to 2016)
Table 3.1. PCR use by country (Top-15 countries 2013 to 2016)
3.2 Organisation types
Figure 3.2. PCR organisation types [country 1] (Top-10 organisations, all PCR 2013 to 2016) 
Table 3.2. PCR organisation types [country 1] (Top-25 organisations, all PCR 2013 to 2016)
3.3 Cities
Figure 3.3. PCR cities in [country 1] (Top-10 cities 2013 to 2016)
Table 3.3. PCR cities in [country 1] (Top 25 cities 2013 to 2016)
3.4 PCR Methods
Figure 3.4. PCR techniques in [country 1] (Top-10 techniques 2013 to 2016)
Table 3.4. PCR techniques in [country 1] (Top-25 techniques 2013 to 2016)
3.5 PCR Applications
Figure 3.5. PCR applications in [country 1] (Top-10 applications 2013 to 2016)
Table 3.5. PCR applications in [country 1] (Top-25 applications 2013 to 2016)
3.6 Clinical & Research
Figure 3.6. Clinical/Research PCR in [country 1] (Clinical/Research 2013 to 2016)
Table 3.6. Clinical/Research PCR in [country 1] (Clinical/Research 2013 to 2016)
3.7 Diseases
Figure 3.7. PCR disease areas in [country 1] (Top-10 disease areas 2013 to 2016)
Table 3.7. PCR disease areas in [country 1] (Top-25 disease areas 2013 to 2016)
3.8 Viruses
Figure 3.8. PCR viruses in [country 1] (Top-10 virus areas 2013 to 2016)
Table 3.8. PCR virus areas in [country 1] (Top-25 virus areas 2013 to 2016)
3.9 Bacteria
Figure 3.9. PCR bacteria in [country 1] (Top-10 bacteria areas 2013 to 2016)
Table 3.9. PCR bacteria areas in [country 1] (Top-25 bacteria areas 2013 to 2016)
3.10 Nucleic Acids
Figure 3.10. PCR nucleic acid types in [country 1] (Top-10 nucleic acids 2013 to 2016)
Table 3.10. PCR nucleic acid types in [country 1] (Top-25 nucleic acids 2013 to 2016)
3.11 PCR Departments
Figure 3.11. PCR departments in [country 1] (Top-10 departments 2013 to 2016)
Table 3.11. PCR departments in [country 1] (Top-25 departments 2013 to 2016)
3.12 Other Techniques
Figure 3.12. Other techniques in [country 1] (Top-10 other techniques 2013 to 2016)
Table 3.12. Other techniques in [country 1] (Top-25 other techniques 2013 to 2016)
3.13 Conclusions

Chapter 4. Organisation Types
Figure 4.1. PCR by organisation types (Top-10 organisation types, PCR 2013 to 2016)
Table 4.1. PCR by organisation types (Top-10 organisation types, PCR 2013 to 2016)
4.2 Cities
Figure 4.2. PCR cities [OrgType 1] (Top-10 cities, PCR 2013 to 2016)
Table 4.2. PCR cities [OrgType 1] (Top-25 PCR cities, PCR 2013 to 2016)
4.3 PCR Methods
Figure 4.3. PCR techniques [OrgType 1] (Top-10 techniques, PCR 2013 to 2016)
Table 4.3. PCR techniques [OrgType 1] (Top-25 techniques, PCR 2013 to 2016)
4.4 PCR Applications
Figure 4.4. PCR applications [OrgType 1] (Top-10 applications, PCR 2013 to 2016)
Table 4.4. PCR applications [OrgType 1] (Top-25 applications, PCR 2013 to 2016)
4.5 Clinical & Research
Figure 4.5. PCR clinical/research [OrgType 1] (clinical/research, PCR 2013 to 2016)
Table 4.5. PCR clinical/research [OrgType 1] (clinical/research, PCR 2013 to 2016)
4.6 Diseases
Figure 4.6. PCR disease areas [OrgType 1] (Top-10 disease areas, PCR 2013 to 2016)
Table 4.6. PCR disease areas [OrgType 1] (Top-25 disease areas, PCR 2013 to 2016)
4.7 Viruses
Figure 4.7. PCR viruses [OrgType 1] (Top-10 viruses, PCR 2013 to 2016)
Table 4.7. PCR viruses [OrgType 1] (Top-25 viruses, PCR 2013 to 2016)
4.8 Bacteria
Figure 4.8. PCR bacteria [OrgType 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 4.8. PCR bacteria [OrgType 1] (Top-25 bacteria, PCR 2013 to 2016)
4.9 Nucleic Acids
Figure 4.9. PCR nucleic acids [OrgType 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 4.9. PCR nucleic acids [OrgType 1] (Top-25 nucleic acids, PCR 2013 to 2016)
4.10 PCR Departments
Figure 4.10. PCR by end-user departments [OrgType 1] (Top-10 departments, PCR 2013 to 2016)
Table 4.10. PCR by end-user departments [OrgType 1] (Top-10 departments, PCR 2013 to 2016)
4.11 Other Techniques
Figure 4.11. Other techniques [OrgType 1] (Top-10 other techniques, PCR 2013 to 2016)
Table 4.11. Other techniques [OrgType 1] (Top-25 other techniques, PCR 2013 to 2016)
4.12 Conclusions

Chapter 5. PCR by User Departments
Figure 5.1. PCR use by department (Top-10 departments, all PCR 2013 to 2016)
Table 5.1. PCR use by department (Top-25 departments, all PCR 2013 to 2016)
5.1 Organisation types
Figure 5.2. PCR organisations of [Dept 1] (Top-10 organisation, PCR 2013 to 2016)
Table 5.2. PCR organisations of [Dept 1] (Top-25 organisation, PCR 2013 to 2016)
5.2 States and Cities
Figure 5.3. PCR cities [Dept 1] (Top-10 cities, PCR 2013 to 2016)
Table 5.3. PCR cities [Dept 1] (Top-25 PCR cities, PCR 2013 to 2016)
5.3 Techniques
Figure 5.5. PCR techniques [Dept 1] (Top-10 techniques, PCR 2013 to 2016)
Table 5.5. PCR techniques [Dept 1] (Top-25 techniques, PCR 2013 to 2016)
5.4 Applications
Figure 5.5. PCR applications [Dept 1] (Top-10 applications, PCR 2013 to 2016)
Table 5.5. PCR applications [Dept 1] (Top-25 applications, PCR 2013 to 2016)
5.5 Clinical & Research
Figure 5.6. PCR clinical/research [Dept 1] (clinical/research, PCR 2013 to 2016)
Table 5.6. PCR clinical/research [Dept 1] (clinical/research, PCR 2013 to 2016)
5.6 Diseases
Figure 5.7. PCR disease areas [Dept 1] (Top-10 disease areas, PCR 2013 to 2016)
Table 5.7. PCR disease areas [Dept 1] (Top-25 disease areas, PCR 2013 to 2016)
5.7 Viruses
Figure 5.8. PCR viruses [Dept 1] (Top-10 viruses, PCR 2013 to 2016)
Table 5.8. PCR viruses [Dept 1] (Top-25 viruses, PCR 2013 to 2016)
5.8 Bacteria
Figure 5.9. PCR bacteria [Dept 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 5.9. PCR bacteria [Dept 1] (Top-25 bacteria, PCR 2013 to 2016)
5.9 Nucleic Acids
Figure 5.10. PCR nucleic acids [Dept 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 5.10. PCR nucleic acids [Dept 1] (Top-25 nucleic acids, PCR 2013 to 2016)
5.10 Other Techniques
Figure 5.11. Other techniques [Dept 1] (Top-10 other techniques, PCR 2013 to 2016)
Table 5.10. Other techniques [Dept 1] (Top-25 other techniques, PCR 2013 to 2016)
5.11 Conclusions

Chapter 6. PCR Methods
Figure 6.1. PCR methods (Top-10 methods, all PCR 2013 to 2016)
Table 6.1. PCR methods (Top-25 methods, all PCR 2013 to 2016)
6.1 Organisation types
Figure 6.2. PCR organisations of [Method 1] (Top-10 organisation, PCR 2013 to 2016)
Table 6.2. PCR organisations of [Method 1] (Top-25 organisation, PCR 2013 to 2016)
6.2 Countries
Figure 6.3. PCR countries [Method 1] (Top-10 countries, PCR 2013 to 2016)
Table 6.3. PCR countries [Method 1] (Top-25 countries, PCR 2013 to 2016)
6.3 Organisation types
Figure 6.4. PCR organisations [Method 1] (Top-10 organisation, PCR 2013 to 2016)
Table 6.4. PCR organisations [Method 1] (Top-25 organisation, PCR 2013 to 2016)
6.4 Cities
Figure 6.6. PCR cities [Method 1] (Top-10 cities, PCR 2013 to 2016)
Table 6.6. PCR cities [Method 1] (Top-25 cities, PCR 2013 to 2016)
6.5 Clinical & Research
Figure 6.6. PCR clinical/research [Method 1] (PCR clinical/research, PCR 2013 to 2016)
Table 6.6. PCR clinical/research [Method 1] (PCR clinical/research, PCR 2013 to 2016)
6.6 Diseases
Figure 6.7. PCR disease areas [Method 1] (Top-10 disease areas, PCR 2013 to 2016)
Table 6.7. PCR disease areas [Method 1] (Top-25 disease areas, PCR 2013 to 2016)
6.7 Viruses
Figure 6.8. PCR viruses [Method 1] (Top-10 viruses, PCR 2013 to 2016)
Table 6.8. PCR viruses of [Method 1] (Top-25 viruses, PCR 2013 to 2016)
6.8 Bacteria
Figure 6.9. PCR bacteria [Method 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 6.9. PCR bacteria of [Method 1] (Top-25 bacteria, PCR 2013 to 2016)
6.9 Nucleic Acids
Figure 6.10. PCR nucleic acids [Method 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 6.10. PCR nucleic acids [Method 1] (Top-25 nucleic acids, PCR 2013 to 2016)
6.10 Departments
Figure 6.11. PCR departments [Method 1] (Top-10 departments, PCR 2013 to 2016)
Table 6.11. PCR departments of [Method 1] (Top-25 departments, PCR 2013 to 2016)
6.11 Other Techniques
Figure 6.12. Other techniques [Method 1] (Top-10 techniques, PCR 2013 to 2016)
Table 6.12. Other techniques [Method 1] (Top-25 techniques, PCR 2013 to 2016)
6.12 Conclusions

Chapter 7. PCR Applications
Figure 7.1. PCR applications (Top-10 applications, all PCR 2013 to 2016)
Table 7.1. PCR applications (Top-25 applications, all PCR 2013 to 2016)
7.1 Organisation types
Figure 7.2. PCR organisations of [App 1] (Top-10 organisations, PCR 2013 to 2016)
Table 7.2. PCR organisations of [App 1] (Top-25 organisation, PCR 2013 to 2016)
7.2 Cities
Figure 7.3. PCR cities [App 1] (Top-10 cities, PCR 2013 to 2016)
Table 7.3. PCR cities [App 1] (Top-25 cities, PCR 2013 to 2016)
7.3 Techniques
Figure 7.4. PCR techniques of [App 1] (Top-10 techniques, PCR 2013 to 2016)
Table 7.4. PCR techniques of [App 1] (Top-25 techniques, PCR 2013 to 2016)
7.4 Clinical & Research
Figure 7.5. Clinical/Research [App 1] (Clinical/Research, PCR 2013 to 2016)
Table 7.5. Clinical/Research [App 1] (Clinical/Research, PCR 2013 to 2016)
7.5 Diseases
Figure 7.7. PCR disease areas [App 1] (PCR disease areas, PCR 2013 to 2016)
Table 7.7. PCR disease areas [App 1] (Top-25 disease areas, PCR 2013 to 2016)
7.6 Viruses
Figure 7.7. PCR viruses [App 1] (Top-10 viruses, PCR 2013 to 2016)
Table 7.7. PCR viruses of [App 1] (Top-25 viruses, PCR 2013 to 2016)
7.7 Bacteria
Figure 7.8. PCR bacteria [App 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 7.8. PCR bacteria of [App 1] (Top-25 bacteria, PCR 2013 to 2016)
7.81 Nucleic Acids
Figure 7.9. PCR nucleic acids [App 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 7.9. PCR nucleic acids of [App 1] (Top-25 nucleic acids, PCR 2013 to 2016)
7.9 Departments
Figure 7.10. PCR departments [App 1] (Top-10 departments, PCR 2013 to 2016)
Table 7.10. PCR departments of [App 1] (Top-25 departments, PCR 2013 to 2016)
7.10 Other Techniques
Figure 7.11. Other techniques [App 1] (Top-10 other techniques, PCR 2013 to 2016)
Table 7.11. Other techniques [App 1] (Top-25 other techniques, PCR 2013 to 2016)
7.11 Conclusions

Chapter 8. Disease Areas
Figure 8.1. PCR disease areas (Top-10 disease areas, all PCR 2013 to 2016)
Table 8.1. PCR disease areas (Top-25 disease areas, all PCR 2013 to 2016)
8.1 Organisation types
Figure 8.2. PCR organisations of [Disease 1] (Top-10 organisations, PCR 2013 to 2016)
Table 8.2. PCR organisations of [Disease 1] (Top-25 organisation, PCR 2013 to 2016)
8.1 Countries
Figure 8.3. PCR countries [Disease 1] (Top-10 countries, PCR 2013 to 2016)
Table 8.3. PCR countries of [Disease 1] (Top-25 countries, PCR 2013 to 2016)
8.3 Cities
Figure 8.4. PCR cities [Disease 1] (Top-10 cities, PCR 2013 to 2016)
Table 8.4. PCR cities of [Disease 1] (Top-25 cities, PCR 2013 to 2016)
8.4 Methods
Figure 8.5. PCR methods [Disease 1] (Top-10 methods, PCR 2013 to 2016)
Table 8.5. PCR methods of [Disease 1] (Top-25 methods, PCR 2013 to 2016)
8.5 Applications
Figure 8.6. PCR application [Disease 1] (Top-10 application, PCR 2013 to 2016)
Table 8.6. PCR application of [Disease 1] (Top-25 application, PCR 2013 to 2016)
8.6 Clinical & Research
Figure 8.8. PCR Clinical/Research [Disease 1] (Clinical/Research, PCR 2013 to 2016)
Table 8.8. Clinical/Research [Disease 1] (Top-25 Clinical/Research, PCR 2013 to 2016)
8.7 Viruses
Figure 8.8. PCR viruses [Disease 1] (Top-10 viruses, PCR 2013 to 2016)
Table 8.8. PCR viruses [Disease 1] (Top-25 viruses, PCR 2013 to 2016)
8.8 Bacteria
Figure 8.9. PCR bacteria [Disease 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 8.9. PCR bacteria [Disease 1] (Top-25 bacteria, PCR 2013 to 2016)
8.9 Nucleic Acids
Figure 8.10. PCR nucleic acids [Disease 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 8.10. PCR nucleic acids [Disease 1] (Top-25 nucleic acids, PCR 2013 to 2016)
8.10 Departments
Figure 8.11. PCR departments [Disease 1] (Top-10 departments, PCR 2013 to 2016)
Table 8.11. PCR departments of [Disease 1] (Top-25 departments, PCR 2013 to 2016)
8.11 Other Techniques
Figure 8.12. Other techniques [Disease 1] (Top-10 techniques, PCR 2013 to 2016)
Table 8.12. PCR techniques of [Disease 1] (Top-25 techniques, PCR 2013 to 2016)
8.12 Conclusions

Chapter 9. Viruses
Figure 9.1. PCR viruses (Top-10 viruses, all PCR 2013 to 2016)
Table 9.1. PCR viruses (Top-25 viruses, all PCR 2013 to 2016)
9.1 Organisation types
Figure 9.2. PCR organisations of [Virus 1] (Top-10 organisations, PCR 2013 to 2016)
Table 9.2. PCR organisations of [Virus 1] (Top-25 organisation, PCR 2013 to 2016)
9.2 Cities
Figure 9.3. PCR cities [Virus 1] (Top-10 cities, PCR 2013 to 2016)
Table 9.3. PCR cities of [Virus 1] (Top-25 cities, PCR 2013 to 2016)
9.3 Methods
Figure 9.4. PCR methods [Virus 1] (Top-10 methods, PCR 2013 to 2016)
Table 9.4. PCR methods of [Virus 1] (Top-25 methods, PCR 2013 to 2016)
9.4 Applications
Figure 9.5. PCR applications [Virus 1] (Top-10 applications, PCR 2013 to 2016)
Table 9.5. PCR applications of [Virus 1] (Top-25 applications, PCR 2013 to 2016)
9.5 Clinical & Research
Figure 9.6. Clinical/Research [Virus 1] (Clinical/Research, PCR 2013 to 2016)
Table 9.6. Clinical/Research [Virus 1] (Clinical/Research, PCR 2013 to 2016)
9.6 Diseases
Figure 9.7. PCR disease areas [Virus 1] (Top-10 disease areas, PCR 2013 to 2016)
Table 9.7. PCR disease areas [Virus 1] (Top-25 disease areas, PCR 2013 to 2016)
9.7 Bacteria
Figure 9.9. PCR bacteria [Virus 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 9.9. PCR bacteria of [Virus 1] (Top-25 bacteria, PCR 2013 to 2016)
9.8 Nucleic Acids
Figure 9.9. PCR nucleic acids [Virus 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 9.9. PCR nucleic acids [Virus 1] (Top-25 nucleic acids, PCR 2013 to 2016)
9.9 Departments
Figure 9.10. PCR departments [Virus 1] (Top-10 departments, PCR 2013 to 2016)
Table 9.10. PCR departments [Virus 1] (Top-25 departments, PCR 2013 to 2016)
9.10 Other Techniques
Figure 9.11. Other techniques [Virus 1] (Top-10 other techniques, PCR 2013 to 2016)
Table 9.11. Other techniques [Virus 1] (Top-25 other techniques, PCR 2013 to 2016)
9.11 Conclusions

Chapter 10. Bacteria
Figure 10.1. PCR viruses (Top-10 viruses, all PCR 2013 to 2016)
Table 10.1. PCR viruses (Top-25 viruses, all PCR 2013 to 2016)
10.1 Countries
Figure 10.2. PCR countries [Bacteria 1] (Top-10 countries, PCR 2013 to 2016)
Table 10.2. PCR countries [Bacteria 1] (Top-25 countries, PCR 2013 to 2016)
10.2 Organisation types
Figure 10.3 Organisation types [Bacteria 1] (Top-10 organisations, PCR 2013 to 2016)
Table 10.3. Organisation types [Bacteria 1] (Top-10 organisations, PCR 2013 to 2016)
10.3 Cities
Figure 10.4. PCR cities [Bacteria 1] (Top-10 cities, PCR 2013 to 2016)
Table 10.4. PCR cities [Bacteria 1] (Top-25 cities, PCR 2013 to 2016)
10.4 Techniques
Figure 10.5. PCR techniques [Bacteria 1] (Top-10 techniques, PCR 2013 to 2016)
Table 10.5. PCR techniques [Bacteria 1] (Top-25 techniques, PCR 2013 to 2016)
10.5 Applications
Figure 10.6. PCR applications [Bacteria 1] (Top-10 applications, PCR 2013 to 2016)
Table 10.6. PCR applications [Bacteria 1] (Top-25 applications, PCR 2013 to 2016)
10.6 Clinical & Research
Figure 10.7. Clinical/Research [Bacteria 1] (Clinical/Research, PCR 2013 to 2016)
Table 10.7. Clinical/Research [Bacteria 1] (Clinical/Research, PCR 2013 to 2016)
10.7 Diseases
Figure 10.8. PCR disease areas [Bacteria 1] (PCR disease areas, PCR 2013 to 2016)
Table 10.8. PCR disease areas [Bacteria 1] (PCR disease areas, PCR 2013 to 2016)
10.8 Viruses
Figure 10.10. PCR viruses [Bacteria 1] (Top-10 viruses, PCR 2013 to 2016)
Table 10.10. PCR viruses [Bacteria 1] (Top-25 viruses, PCR 2013 to 2016)
10.9 Nucleic Acids
Figure 10.10. PCR nucleic acids [Bacteria 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 10.10. PCR nucleic acids [Bacteria 1] (Top-25 nucleic acids, PCR 2013 to 2016)
10.10 Departments
Figure 10.11. PCR departments [Bacteria 1] (Top-10 departments, PCR 2013 to 2016)
Table 10.11. PCR departments [Bacteria 1] (Top-25 departments, PCR 2013 to 2016)
10.11 Other Techniques
Figure 10.12. Other techniques [Bacteria 1] (Top-10 techniques, PCR 2013 to 2016)
Table 10.12. Other techniques [Bacteria 1] (Top-25 techniques, PCR 2013 to 2016)
10.12 Conclusions

Chapter 11. Clinical and Research
Figure 11.1. Clinical (Top-10 PCR methods, all PCR 2013 to 2016)
Table 11.1. Clinical (Top-25 PCR methods, all PCR 2013 to 2016)
Figure 11.2. Research (Top-10 PCR methods, all PCR 2013 to 2016)
Table 11.2. Research (Top-25 PCR methods, all PCR 2013 to 2016)
11.1 Countries
Figure 11.3. PCR countries [Clinical] (Top-10 countries, PCR 2013 to 2016)
Table 11.3. PCR countries [Clinical] (Top-25 countries, PCR 2013 to 2016)
Figure 11.4. PCR countries [Research] (Top-10 countries, PCR 2013 to 2016)
Table 11.4. PCR countries [Research] (Top-25 countries, PCR 2013 to 2016)
11.2 Organisation types
Figure 11.5. PCR organisation types [Clinical] (Top-10 organisations, PCR 2013 to 2016)
Table 11.5. PCR organisation types [Clinical] (Top-25 organisations, PCR 2013 to 2016)
Figure 11.6. PCR organisation types [Research] (Top-10 organisations, PCR 2013 to 2016)
Table 11.6. PCR organisation types [Research] (Top-25 organisations, PCR 2013 to 2016)
11.3 Cities
Figure 11.7. PCR cities [Clinical] (Top-10 cities, PCR 2013 to 2016)
Table 11.7. PCR cities [Clinical] (Top-25 cities, PCR 2013 to 2016)
Figure 11.8. PCR cities [Research] (Top-10 cities, PCR 2013 to 2016)
Table 11.8. PCR cities [Research] (Top-25 cities, PCR 2013 to 2016)
11.4 Methods
Figure 11.9. PCR methods [Clinical] (Top-10 methods, PCR 2013 to 2016)
Table 11.9. PCR methods [Clinical] (Top-25 methods, PCR 2013 to 2016)
Figure 11.11. PCR methods [Research] (Top-10 methods, PCR 2013 to 2016)
Table 11.11. PCR methods [Research] (Top-25 methods, PCR 2013 to 2016)
11.5 Applications
Figure 11.11. PCR applications [Clinical] (Top-10 applications, PCR 2013 to 2016)
Table 11.11. PCR applications [Clinical] (Top-25 applications, PCR 2013 to 2016)
Figure 11.12. PCR applications [Research] (Top-10 applications, PCR 2013 to 2016)
Table 11.12. PCR applications [Research] (Top-25 applications, PCR 2013 to 2016)
11.6 Diseases
Figure 11.13. PCR diseases [Clinical] (Top-10 diseases, PCR 2013 to 2016)
Table 11.13. PCR diseases [Clinical] (Top-25 diseases, PCR 2013 to 2016)
Figure 11.14. PCR diseases [Research] (Top-10 diseases, PCR 2013 to 2016)
Table 11.14. PCR diseases [Research] (Top-25 diseases, PCR 2013 to 2016)
11.7 Viruses
Figure 11.15. PCR viruses [Clinical] (Top-10 viruses, PCR 2013 to 2016)
Table 11.15. PCR viruses [Clinical] (Top-25 viruses, PCR 2013 to 2016)
Figure 11.16. PCR viruses [Research] (Top-10 viruses, PCR 2013 to 2016)
Table 11.16. PCR viruses [Research] (Top-25 viruses, PCR 2013 to 2016)
11.8 Bacteria
Figure 11.17. PCR bacteria [Clinical] (Top-10 bacteria, PCR 2013 to 2016)
Table 11.17. PCR bacteria [Clinical] (Top-25 bacteria, PCR 2013 to 2016)
Figure 11.18. PCR bacteria [Research] (Top-10 bacteria, PCR 2013 to 2016)
Table 11.18. PCR bacteria [Research] (Top-25 bacteria, PCR 2013 to 2016)
11.9 Nucleic Acids
Figure 11.19. PCR nucleic acids [Clinical] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 11.19. PCR nucleic acids [Clinical] (Top-25 nucleic acids, PCR 2013 to 2016)
Figure 11.20. PCR nucleic acids [Research] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 11.20. PCR nucleic acids [Research] (Top-25 nucleic acids, PCR 2013 to 2016)
11.10 Departments
Figure 11.21. PCR departments [Clinical] (Top-10 departments, PCR 2013 to 2016)
Table 11.21. PCR departments [Clinical] (Top-25 departments, PCR 2013 to 2016)
Figure 11.22. PCR departments [Research] (Top-10 departments, PCR 2013 to 2016)
Table 11.22. PCR departments [Research] (Top-25 departments, PCR 2013 to 2016)
11.11 Other Techniques
Figure 11.23. Other techniques [Clinical] (Top-10 other techniques, PCR 2013 to 2016)
Table 11.23. Other techniques [Clinical] (Top-25 other techniques, PCR 2013 to 2016)
Figure 11.24. Other techniques [Research] (Top-10 other techniques, PCR 2013 to 2016)
Table 11.24. Other techniques [Research] (Top-25 other techniques, PCR 2013 to 2016)
11.12 Conclusions

Chapter 12. Nucleic Acids
Figure 12.1. PCR nucleic acids (Top-10 nucleic acids, all PCR 2013 to 2016)
Table 12.1. PCR nucleic acids (Top-25 nucleic acids, all PCR 2013 to 2016)
12.1 Countries
Figure 12.2. PCR countries [Nucleic Acid 1] (Top-10 countries, PCR 2013 to 2016)
Table 12.2. PCR countries [Nucleic Acid 1] (Top-25 countries, PCR 2013 to 2016)
12.2 Organisation types
Figure 12.3. PCR organisation types [Nucleic Acid 1] (Top-10 organisations types, PCR 2013 to 2016)
Table 12.3. PCR organisation types [Nucleic Acid 1] (Top-25 organisations types, PCR 2013 to 2016)
12.3 Cities
Figure 12.4. PCR cities [Nucleic Acid 1] (Top-10 cities, PCR 2013 to 2016)
Table 12.4. PCR cities types [Nucleic Acid 1] (Top-25 cities types, PCR 2013 to 2016)
12.4 Techniques
Figure 12.5. PCR methods [Nucleic Acid 1] (Top-10 methods, PCR 2013 to 2016)
Table 12.5. PCR methods [Nucleic Acid 1] (Top-25 methods, PCR 2013 to 2016)
12.5 Applications
Figure 12.6. PCR applications [Nucleic Acid 1] (Top-10 applications, PCR 2013 to 2016)
Table 12.6. PCR applications [Nucleic Acid 1] (Top-25 applications, PCR 2013 to 2016)
12.6 Clinical & Research
Figure 12.7. Clinical/Research [Nucleic Acid 1] (clinical/research, PCR 2013 to 2016)
Table 12.7. Clinical/Research [Nucleic Acid 1] (clinical/research, PCR 2013 to 2016)
12.7 Diseases
Figure 12.8. PCR disease areas [Nucleic Acid 1] (Top-10 disease areas, PCR 2013 to 2016)
Table 12.8. PCR disease areas [Nucleic Acid 1] (Top-25 disease areas, PCR 2013 to 2016)
12.8 Viruses
Figure 12.9. PCR viruses [Nucleic Acid 1] (Top-10 viruses, PCR 2013 to 2016)
Table 12.9. PCR viruses [Nucleic Acid 1] (Top-25 viruses, PCR 2013 to 2016)
12.9 Bacteria
Figure 12.10. PCR bacteria [Nucleic Acid 1] (Top-10 bacteria, PCR 2013 to 2016)
Table 12.10. PCR bacteria [Nucleic Acid 1] (Top-25 bacteria, PCR 2013 to 2016)
12.10 Nucleic Acids
Figure 12.12. PCR nucleic acids [Nucleic Acid 1] (Top-10 nucleic acids, PCR 2013 to 2016)
Table 12.12. PCR nucleic acids [Nucleic Acid 1] (Top-25 nucleic acids, PCR 2013 to 2016)
12.11 Departments
Figure 12.12. PCR departments [Nucleic Acid 1] (Top-10 departments, PCR 2013 to 2016)
Table 12.12. PCR departments [Nucleic Acid 1] (Top-25 departments, PCR 2013 to 2016)
12.12 Other Techniques
Figure 12.13. Other molecular techniques [Nucleic Acid 1] (Top-10 techniques, PCR 2013 to 2016)
Table 12.13. Other molecular techniques [Nucleic Acid 1] (Top-25 techniques, PCR 2013 to 2016)
12.13 Conclusions

Chapter 13. Other Molecular Techniques
Figure 13.1. PCR nucleic acids (Top-10 nucleic acids, all PCR 2013 to 2016)
Table 13.1. PCR nucleic acids (Top-25 nucleic acids, all PCR 2013 to 2016)
13.1 Countries
Figure 13.2. PCR countries [Other Technique 1] (Top-10 countries, PCR 2013 to 2016)
Table 13.2. PCR countries [Other Technique 1] (Top-25 countries, PCR 2013 to 2016)
13.2 Organisation types
Figure 13.3. PCR organisation types [Other Technique 1] (Top-10 organisations, PCR 2013 to 2016)
Table 13.3. PCR organisation types [Other Technique 1] (Top-25 organisations, PCR 2013 to 2016)
13.3 Cities
Figure 13.4. PCR cities [Other Technique 1] (Top-10 cities PCR 2013 to 2016)
Table 13.4. PCR cities [Other Technique 1] (Top-25 cities PCR 2013 to 2016)
13.4 Applications
Figure 13.5. PCR applications [Other Technique 1] (Top-10 applications PCR 2013 to 2016)
Table 13.5. PCR applications [Other Technique 1] (Top-25 applications PCR 2013 to 2016)
13.5 Clinical & Research
Figure 13.6. PCR cities [Other Technique 1] (Top-10 cities PCR 2013 to 2016)
Table 13.6. PCR cities [Other Technique 1] (Top-25 cities PCR 2013 to 2016)
13.6 Diseases
Figure 13.7. PCR disease areas [Other Technique 1] (Top-10 disease areas PCR 2013 to 2016)
Table 13.7. PCR disease areas [Other Technique 1] (Top-25 disease areas PCR 2013 to 2016)
13.7 Viruses
Figure 13.8. PCR viruses [Other Technique 1] (Top-10 viruses PCR 2013 to 2016)
Table 13.8. PCR viruses [Other Technique 1] (Top-25 viruses PCR 2013 to 2016)
13.8 Bacteria
Figure 13.9. PCR bacteria [Other Technique 1] (Top-10 bacteria PCR 2013 to 2016)
Table 13.9. PCR bacteria [Other Technique 1] (Top-25 bacteria PCR 2013 to 2016)
13.9 Nucleic Acids
Figure 13.10. PCR nucleic acids [Other Technique 1] (Top-10 nucleic acids PCR 2013 to 2016)
Table 13.10. PCR nucleic acids [Other Technique 1] (Top-25 nucleic acids PCR 2013 to 2016)
13.10 Departments
Figure 13.11. PCR departments [Other Technique 1] (Top-10 departments PCR 2013 to 2016)
Table 13.11. PCR departments [Other Technique 1] (Top-25 departments PCR 2013 to 2016)
13.11 Other Techniques
Figure 13.13. Other molecular techniques [Other Technique 1] (Top-10 techniques PCR 2013 to 2016)
Table 13.13. Other molecular techniques [Other Technique 1] (Top-25 techniques PCR 2013 to 2016)
13.12 Conclusions

Chapter 14. Discussion
14.1 Top PCR Markets and Opportunities
14.2 PCR Growth and Opportunities
14.3 PCR Qualified Prospects and Opportunities
14.4 PCR End-User Costs
14.5 Key Findings

Reviews

Write Your Own Review

Only registered users can write reviews. Please, log in or register